FOXA vs IMRX · P/E 14, $24.50B cap vs $124.2M cap
Fox Corp Class A (FOXA) versus Immuneering Corp (IMRX) — a side-by-side from cached financials, not a winner call.
Fox Corp Class A (FOXA) is a entertainment company listed on US.
Immuneering Corp (IMRX) is a biotechnology company listed on US.
FOXA does not have a complete income-statement cache yet.
Latest reported IMRX revenue for 2023-12-31 was $0. Net income was -$53.5M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. IMRX currently screens at market cap $124.2M.
FOXA currently screens at market cap $24.50B and trailing P/E 14.1. IMRX currently screens at market cap $124.2M.
Not investment advice. Open the FOXA and IMRX stock pages for the full models.
Not investment advice.